Diamyd Medical AB (OSTO:DMYD B) Other Operating Expense : kr55.91 Mil (TTM As of May. 2025)

View and export this data going back to 2013. Start your Free Trial

What is Diamyd Medical AB Other Operating Expense?

Diamyd Medical AB's Other Operating Expense for the three months ended in May. 2025 was kr15.49 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in May. 2025 was kr55.91 Mil.

Diamyd Medical AB's quarterly Other Operating Expense declined from Nov. 2024 (kr15.77 Mil) to Feb. 2025 (kr13.43 Mil) but then increased from Feb. 2025 (kr13.43 Mil) to May. 2025 (kr15.49 Mil).

Diamyd Medical AB's annual Other Operating Expense increased from Aug. 2022 (kr35.42 Mil) to Aug. 2023 (kr42.85 Mil) and increased from Aug. 2023 (kr42.85 Mil) to Aug. 2024 (kr47.21 Mil).

Diamyd Medical AB Other Operating Expense Historical Data

The historical data trend for Diamyd Medical AB's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Diamyd Medical AB Other Operating Expense Chart

Diamyd Medical AB Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Aug24

Other Operating Expense

Get a 7-Day Free Trial

-27.70

26.77

35.42

42.85

47.21

Diamyd Medical AB Quarterly Data
	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24	May24	Aug24	Nov24	Feb25	May25
Other Operating Expense	Get a 7-Day Free Trial															12.86	11.22	15.77	13.43	15.49

Diamyd Medical AB Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in May. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was kr55.91 Mil.

Diamyd Medical AB Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Diamyd Medical AB's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Diamyd Medical AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Diamyd Medical AB (OSTO:DMYD B) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

DYMDF:USA

Address

Kungsgatan 29, Stockholm, SWE, SE-111 56

Website

https://www.diamyd.com

Diamyd Medical AB is a Sweden-based company engaged in the field of pharmaceutical development. It develops therapies using in-licensed substances glutamic acid decarboxylase (GAD) and GABA for the prevention or treatment of diabetes and other inflammatory diseases. The firm is focused on finding the cure for diabetes and other serious inflammatory diseases through pharmaceutical development and investments in stem cells and medical technology. Its product portfolio consists of Diamyd, for the treatment of autoimmune diabetes; Remygen, a regenerative and immunomodulatory therapy for the treatment of autoimmune diabetes and type 2 and type 1 diabetes.

Diamyd Medical AB Headlines

No Headlines